Alternative therapies are also available for estrogen-dependent breast cancer which includes the use of aromatase inhibitors (AI) (anastrozole, letrozole, and exemestane) that impede the biosynthesis of androgens in tumor by down-regulating the aromatase enzyme (Chumsri et al., 2011). The gene discussed is CYP19A1; the disease is neoplasm.